Showing results (111-120 of 191) with videos related to
Sort By:
Pageof 20
Nature Protocols|December 14, 2021
Hyperosmolar blood-brain barrier opening using intra-arterial injection of hyperosmotic mannitol in mice under real-time MRI guidanceChengyan Chu, Anna Jablonska, Yue Gao, et al.Stroke|September 9, 2021
Serum Sphingosine-1-Phosphate Levels Are Associated With Severity and Outcome in Patients With Cerebral IschemiaEdzard Schwedhelm, Laura Schwieren, Steffen Tiedt, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|January 12, 2012
The flavonoid fisetin attenuates postischemic immune cell infiltration, activation and infarct size after transient cerebral middle artery occlusion in miceMathias Gelderblom, Frank Leypoldt, Jan Lewerenz, et al.Stroke|March 7, 2009
Temporal and spatial dynamics of cerebral immune cell accumulation in strokeMathias Gelderblom, Frank Leypoldt, Karin Steinbach, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|October 8, 2025
Associations of sphingosine-1-phosphate with soluble P-selectin and adverse clinical outcome in patients with cerebral ischemia with and without acetylsalicylic acid treatmentNils-Ole Gloyer, Eileen Moritz, Laura Schwieren, et al.Life (Basel, Switzerland)|July 29, 2023
Homoarginine Associates with Carotid Intima-Media Thickness and Atrial Fibrillation and Predicts Adverse Events after StrokeLaura Schwieren, Märit Jensen, Robert Schulz, et al.Acta Biomaterialia|May 30, 2026
Genetically Engineered Bacterial Magnetosomes as Optimized Tracers for Magnetic Particle ImagingFlorian Thieben, Frank Mickoleit, René Uebe, et al.Stroke|April 19, 2014
Blocking of α4 integrin does not protect from acute ischemic stroke in miceFriederike Langhauser, Peter Kraft, Eva Göb, et al.The Journal of Comparative Neurology|October 24, 2007
Patterns of laminins and integrins in the embryonic ventricular zone of the CNSJustin D Lathia, Bruce Patton, D Mark Eckley, et al.Frontiers in Immunology|November 7, 2022
Evaluation of nanobody-based biologics targeting purinergic checkpoints in tumor models <i>in vivo</i>Mélanie Demeules, Allan Scarpitta, Romain Hardet, et al.Pageof 20